| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 03/24/2004 | CN1484526A Perturbed membrane-binding compounds |
| 03/24/2004 | CN1484499A Method for molecular press dehydration of plant tissue using solid phase water-soluble polymer as de hydrating agent |
| 03/24/2004 | CN1483478A Eye preparation formula adapted for therapentic medicine |
| 03/24/2004 | CN1483477A Vaccin composition, preparation method and use thereof |
| 03/24/2004 | CN1483406A Maltilate emulsion and preparation proless thereof |
| 03/24/2004 | CN1483401A Slow-released preparation |
| 03/24/2004 | CN1142940C Pharmaceutical compsns. containing an MPL ligand |
| 03/24/2004 | CN1142935C Comptothecin compounds and preparation thereof |
| 03/24/2004 | CN1142902C Alk (En)yl dicarboxylic acid bisesters, their use and method for preparing them |
| 03/24/2004 | CN1142794C Photostable aqueous solution containing benzyl alcohol derivatives |
| 03/24/2004 | CN1142791C Gel formulations containing growth factors |
| 03/24/2004 | CN1142782C Dexamethasone gel |
| 03/24/2004 | CN1142780C Pharmaceutical compositions |
| 03/24/2004 | CN1142772C Lipophilic microparticles containing protein drug or antigen and formulation comprising same |
| 03/23/2004 | US6710195 Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositions |
| 03/23/2004 | US6710169 Adheson variants |
| 03/23/2004 | US6710125 Reacting a terminal hydroxyl group of a water-soluble and non-peptidic polymer with di(1-benzotriazolyl) carbonate in peresence of amine base and organic solvent |
| 03/23/2004 | US6710086 Chemically modified pharmacologically active agent in carrier; reduce the damage to the gastrointestinal tract |
| 03/23/2004 | US6710081 One or more compounds selected from prostaglandin derivatives or cyclodextrin clathrate compounds |
| 03/23/2004 | US6710050 Pharmaceutical composition and the process for its preparation |
| 03/23/2004 | US6709713 Edible coating composition |
| 03/23/2004 | US6709681 Acidified nitrite as an antimicrobial agent |
| 03/23/2004 | US6709679 Antineoplastic conjugates of transferin, albumin and polyethylene glycol |
| 03/23/2004 | US6709677 Combining a sustained release excipient comprises a gelling agent, an ionizable gel strength enhancer and inert diluent with a medicament in amorphous form and a wetting agent and then drying and millilng the combined mixture |
| 03/23/2004 | US6709676 Bilayer solid comprising an immediate release first layer of desloratadine, and an antioxidant or group 2a or aluminum salts and excipient, and a sustained release second layer of nasal decongestant such as pseudoephedrine sulfate |
| 03/23/2004 | US6709674 Injectable pamidronate disodium |
| 03/23/2004 | US6709671 Water soluble film for oral administration with instant wettability |
| 03/23/2004 | US6709669 Subliming solvent without gelling; rapidly dissolves in saliva |
| 03/23/2004 | US6709668 Hydrogel-forming system with hydrophobic and hydrophilic components |
| 03/23/2004 | US6709663 Topical emulsion; quaternary ammonium salt emulsifier |
| 03/23/2004 | US6709652 Radioactive labeling of biotin |
| 03/23/2004 | US6709379 Implant with cavities containing therapeutic agents |
| 03/23/2004 | US6708822 Compositions and kits for compounding pharmaceuticals |
| 03/23/2004 | CA2201864C Method of coating particles |
| 03/23/2004 | CA2118584C Fatty acid terminated polyanhydrides |
| 03/19/2004 | CA2440914A1 Process for sterilization of protein containing biological compositions |
| 03/18/2004 | WO2004022657A2 Increasing of the resorption of substances via skin and mucous membranes |
| 03/18/2004 | WO2004022630A2 Water-soluble polymer alkanals |
| 03/18/2004 | WO2004022584A1 Fiber-shaping peptides capable of interacting with self-assembling peptides |
| 03/18/2004 | WO2004022583A1 Versatile linker compound and ligand, and method for preparation thereof |
| 03/18/2004 | WO2004022577A2 Long acting erythropoietins that maintain tissue protective activity of endogenous erythropoietin |
| 03/18/2004 | WO2004022538A1 Crystal for oral solid drug and oral solid drug for dysuria treatment containing the same |
| 03/18/2004 | WO2004022216A1 Compound consisting of precipitated silica and phosphate and use thereof as nutrient intake liquid support and as anticaking agent with nutrient intake |
| 03/18/2004 | WO2004022128A2 Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols |
| 03/18/2004 | WO2004022124A1 Medical device having hydration inhibitor |
| 03/18/2004 | WO2004022105A2 Preparation of m(co)3-complexes by solid phase techniques via metal assisted cleavage from the solid support |
| 03/18/2004 | WO2004022102A2 Pharmaceutical formulation with non-steroidal antiphlogistic agents and nucleic acids for the internalization of nucleic acids into eucaryotic cells |
| 03/18/2004 | WO2004022100A1 Soild nano pharmaceutical formulation and preparation method thereof |
| 03/18/2004 | WO2004022099A2 Cyclodextrin-based polymers for delivering the therapeutic agents covalently bound thereto |
| 03/18/2004 | WO2004022089A1 Minibrain homologous proteins involved in the regulation of energy homeostasis |
| 03/18/2004 | WO2004022064A1 Methods of treatment of male erectile dysfunction |
| 03/18/2004 | WO2004022063A1 Transparent eye drops containing latanoprost |
| 03/18/2004 | WO2004022037A1 Taste masked dosage forms and processes for their preparation |
| 03/18/2004 | WO2004022034A1 Dermatological preparation for the treatment of skin lesions |
| 03/18/2004 | WO2004022032A2 Pharmaceutical dosage form comprising a sulfite compound |
| 03/18/2004 | WO2004022029A2 Branched alcohol-based personal care compositions |
| 03/18/2004 | WO2004022015A1 Use of diketopiperazine derivatives as photostable uv-filters in cosmetic and pharmaceutical preparations |
| 03/18/2004 | WO2004021999A2 Use of histamine h4 receptor modulators for the treatment of allergy and asthma |
| 03/18/2004 | WO2004021993A2 Modified asialo-interferons and uses thereof |
| 03/18/2004 | WO2004021968A2 Solution for ungual application |
| 03/18/2004 | WO2004021861A2 Targeted release |
| 03/18/2004 | WO2004009116A3 Hapten-carrier conjugates comprising virus like particles and uses thereof |
| 03/18/2004 | WO2004006962A3 A tissue factor binding immunoconjugate comprising factor viia |
| 03/18/2004 | WO2004006885A3 Systems for releasing active ingredients, based on biodegradable or biocompatible polymers with a shape memory effect |
| 03/18/2004 | WO2003102116A3 Oil-soluble pigment compositions |
| 03/18/2004 | WO2003097663A3 Immunogenic, monoclonal antibody comprising at least 2 different epitopes of a tumor-associated antigen |
| 03/18/2004 | WO2003094972A3 Fap-activated anti-tumor prodrugs |
| 03/18/2004 | WO2003092623A3 Calicheamicin derivative-carrier conjugates |
| 03/18/2004 | WO2003090744A8 Antibacterial compositions comprising metal phthalocyanine analogues |
| 03/18/2004 | WO2003086305A3 Biodegradable peg-based polymer formulations in ocular applications |
| 03/18/2004 | WO2003079972A3 Active agent delivery systems and methods for protecting and administering active agents |
| 03/18/2004 | WO2003077885A3 Free-base formulations of local anesthetics |
| 03/18/2004 | WO2003070750A3 Rna interference mediated inhibition of hepatitis c virus |
| 03/18/2004 | WO2003053470A3 Pulsed bio-agent delivery systems based on degradable polymer solutions or hydrogels |
| 03/18/2004 | WO2003047499A3 Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting |
| 03/18/2004 | WO2003039435A3 Process of obtaining colloidal dispersions of amphotercin b; compounds based on amphothericine b for enteral, paraenteral and topical use; use of these compounds in the treatment of systemic mycoses and parasitic infections |
| 03/18/2004 | WO2003039434A3 Process of preparation of formulations of the peptide angiotensin-(1-7) and its analogues, agonistic and antagonists using cyclodextrins, lipossomes and biodegradable polymers and/or mixtures and products thereof |
| 03/18/2004 | WO2003028630A3 Methods and compositions for modulating interleukin-21 receptor activity |
| 03/18/2004 | WO2003026563A3 Conjugated anti-psychotic drugs and uses thereof |
| 03/18/2004 | WO2003015809A3 Antimicrobial cationic peptides and formulations thereof |
| 03/18/2004 | WO2003007874A3 Anti-tumor activity from reptile serum |
| 03/18/2004 | WO2002103029A3 Methods for sterilizing preparations of monoclonal immunoglobulins |
| 03/18/2004 | WO2002085419A3 Bifunctional-modified hydrogels |
| 03/18/2004 | WO2002062396A3 Enhanced oral and transcompartmental delivery of therapeutic or diagnostic agents using polymer conjugates |
| 03/18/2004 | US20040054313 Mixture with flow control agents; antiulcer agents |
| 03/18/2004 | US20040054213 Ophthalmic compositions for treating ocular hypertension |
| 03/18/2004 | US20040054132 Comprises fatty acid-conjugated products with disulfide linkage to proteins/peptides for delivery to cells; increases absorption and prolongs blood and tissue retention |
| 03/18/2004 | US20040054015 Gel for treatment of skin diseases |
| 03/18/2004 | US20040054012 Which can be utilized in injectable preparations being stable over a long period, and containing, for example, phenolic or polyphenolic substances, amino alcohols or sulphur-containing substances |
| 03/18/2004 | US20040054001 For preparing a pharmaceutical composition for treating diseases that may be influenced by NF-kappaB, particularly psoriasis |
| 03/18/2004 | US20040053993 Compositions of tocol-soluble therapeutics |
| 03/18/2004 | US20040053978 Pharmaceutical compositions and methods of using C-21 modified epothilone derivatives |
| 03/18/2004 | US20040053976 Terminally-branched polymeric linkers and polymeric conjugates containing the same |
| 03/18/2004 | US20040053901 A skin permeation enhancer for enhancing absorption of a steroid hormone through the skin, containing an organic solvent, a fatty (C8-C20) alcohol ester of a hydroxy acid, a lower alkyl ester of hydroxy acid and a (C6-C18) fatty acid |
| 03/18/2004 | US20040053899 Method of preparing a pharmaceutical composition |
| 03/18/2004 | US20040053896 Pharmaceutically active compound |
| 03/18/2004 | US20040053894 Improved water solubility; drug delivery; avoids irritation |
| 03/18/2004 | US20040053888 Cyclodextrin-containing pharmaceutical preparation |
| 03/18/2004 | US20040053875 Comprises double-stranded RNA; extracted from HeLa cells |
| 03/18/2004 | US20040053873 Electroporation methods for introducing bioactive agents into cells |